+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Healthcare Specialty Enzymes Global Market Opportunities And Strategies To 2031

  • PDF Icon

    Report

  • 325 Pages
  • November 2022
  • Region: Global
  • The Business Research Company
  • ID: 5684018
This report describes and explains the healthcare specialty enzymes market and covers 2016-2021, termed the historic period, and 2021-2026 termed the forecast period, along with further forecasts for the period 2026-2031. The report evaluates the market across each region and for the major economies within each region.

The global healthcare specialty enzymes market reached a value of nearly $2,198.63 million in 2021, having grown at a compound annual growth rate (CAGR) of 2.84% since 2016. The market is expected to grow from $2,198.63 million in 2021 to $3,003.00 million in 2026 at a rate of 6.43%. The market is then expected to grow at a CAGR of 7.63% from 2026 and reach $4,338.00 million in 2031.

Growth in the historic period resulted from a rise in demand for non-harmful biological catalyst, increasing prevalence of chronic diseases, an increase in cardiovascular diseases (CVDs), growing government initiatives, a rapid growth in aging population and an increase in investments. Factors that negatively affected growth in the historic period were low healthcare access and regulatory challenges.

Going forward, rising use of enzymes in DNA sequencing and manipulation, aging population, advancement in enzyme engineering, an increase in diabetes cases, a rise in healthcare expenditure and sedentary lifestyles will drive the growth. Factors that could hinder the growth of the healthcare specialty enzymes market in the future include safety concerns, a lack of skilled/trained molecular biologists and insufficient and outdated health systems.

The healthcare specialty enzymes market is segmented by type into carbohydrases, proteases, lipases, polymerases and nucleases, oxidase and hydratases and other types. The carbohydrases market was the largest segment of the healthcare specialty enzymes market segmented by type, accounting for 24.16% of the total in 2021. Going forward, the polymerases and nucleases segment is expected to be the fastest growing segment in the healthcare specialty enzymes market segmented by type, at a CAGR of 7.24% during 2021-2026.

The healthcare specialty enzymes market is segmented by source into microorganisms, animals and plants. The microorganism’s market was the largest segment of the healthcare specialty enzymes market segmented by source, accounting for 55.02% of the total in 2021. Going forward, the microorganism’s segment is expected to be the fastest growing segment in the healthcare specialty enzymes market segmented by source, at a CAGR of 6.63% during 2021-2026.

The healthcare specialty enzymes market is also segmented by application into pharmaceuticals, research and biotechnology, diagnostics and biocatalysts. The pharmaceuticals market was the largest segment of the healthcare specialty enzymes market segmented by application, accounting for 55.50% of the total in 2021. Going forward, pharmaceuticals segment is expected to be the fastest growing segment in the healthcare specialty enzymes market segmented by application, at a CAGR of 6.72% during 2021-2026.

North America was the largest region in the healthcare specialty enzymes market, accounting for 39.75% of the total in 2021. It was followed by Asia Pacific, and then the other regions. Going forward, the fastest-growing regions in the healthcare specialty enzymes market will be Asia Pacific and North America where growth will be at CAGRs of 7.12% and 6.62% respectively. These will be followed by Western Europe and South America where the markets are expected to grow at CAGRs of 6.28% and 6.08% respectively.

The global healthcare specialty enzymes market is fragmented, with a large number of small players. The top ten competitors in the market made up to 28.35% of the total market in 2021. Companies in the market majorly focus on expanding their businesses and undertaking strategies, such as mergers and acquisitions, expansions, and novel product innovations. Partnership is also preferred by companies, in order to strengthen their market presence and develop innovative products together. F. Hoffmann-La Roche AG was the largest competitor with 17.38% share of the market, followed by Merck Millipore with 5.46%, Thermo Fisher Scientific Inc. (Affymetrix, Inc.) with 1.63%, Codexis, Inc. with 1.45%, Sekisui Diagnostics with 0.52%, Amicogen with 0.52%, Biocatalysts Ltd with 0.49%, Advanced Enzymes with 0.36%, New England Biolabs with 0.31% and Amano Enzyme Inc. with 0.24%.

The top opportunities in the healthcare specialty enzymes market segmented by type will arise in the polymerases and nucleases segment, which will gain $211.86 million of global annual sales by 2026. The top opportunities in the healthcare specialty enzymes market segmented by source will arise in the microorganisms segment, which will gain $457.54 million of global annual sales by 2026. The top opportunities in the healthcare specialty enzymes market segmented by application will arise in the pharmaceuticals segment, which will gain $468.74 million of global annual sales by 2026. The healthcare specialty enzymes market size will gain the most in the USA at $309.94 million.

Market-trend-based strategies for the healthcare specialty enzymes market include technological advancements in the biotechnology sector, investments in research and biotechnology sector, new product launches, advancement in enzyme engineering, partnerships, collaborations, and agreements, integration of machine learning and artificial intelligence and increasing shift towards enzyme-based diagnostic biosensors.

Player-adopted strategies in the healthcare specialty enzymes market include investing in strengthening product portfolio by launching new products, expanding business presence through collaborations and mergers and acquisitions, focusing on increasing the depth of capabilities in technologies, software and services, leveraging extensive global channels to address customers’ emerging needs, strengthening research and development capabilities through different innovation centers and focusing on capacity additions to accelerate scientific exploration.

To take advantage of the opportunities, the publisher recommends the healthcare specialty enzymes companies to focus on new product launches, focus on advancements in enzyme engineering, integrate machine learning and artificial intelligence, expand in emerging economies, continue to focus on developed markets, focus on strategic partnerships and collaborations, offer competitive prices, continue to use B2B promotions, continue to participate in events and conferences and target fast-growing applications.

Frequently Asked Questions about the Global Healthcare Specialty Enzymes Market

What is the estimated value of the Global Healthcare Specialty Enzymes Market?

The Global Healthcare Specialty Enzymes Market was estimated to be valued at $2198.63 Million in 2021.

What is the growth rate of the Global Healthcare Specialty Enzymes Market?

The growth rate of the Global Healthcare Specialty Enzymes Market is 7.0%, with an estimated value of $4338 Million by 2031.

What is the forecasted size of the Global Healthcare Specialty Enzymes Market?

The Global Healthcare Specialty Enzymes Market is estimated to be worth $4338 Million by 2031.

Who are the key companies in the Global Healthcare Specialty Enzymes Market?

Key companies in the Global Healthcare Specialty Enzymes Market include F. Hoffmann, La Roche AG, Merck Millipore, Thermo Fisher Scientific Inc. (Affymetrix, Inc.) and Sekisui Diagnostics.

Table of Contents

1. Executive Summary2. Table of Contents3. List of Figures4. List of Tables5. Report Structure
6. Introduction and Market Characteristics
6.1. General Market Definition
6.2. Summary
6.3. Healthcare Specialty Enzymes Market Definition and Segmentations
6.4. Market Segmentation By Type
6.4.1. Carbohydrases
6.4.2. Proteases
6.4.3. Lipases
6.4.4. Polymerases And Nucleases
6.4.5. Oxidase And Hydratases
6.4.6. Other Types
6.5. Market Segmentation By Source
6.5.1. Microorganisms
6.5.2. Animals
6.5.3. Plants
6.6. Market Segmentation By Application
6.6.1. Pharmaceuticals
6.6.2. Research And Biotechnology
6.6.3. Diagnostics
6.6.4. Biocatalysts
7. Major Market Trends
7.1. Technological Advancements In Biotechnology Sector
7.2. Increasing Investments In Research And Biotechnology Sector
7.3. Product Launch
7.4. Advancement In Enzyme Engineering
7.5. Partnerships, Collaborations, and Agreements
7.6. Integration Of Machine Learning And Artificial Intelligence
7.7. Increasing Shift Towards Enzyme-Based Diagnostic Biosensors
8. Global Market Size And Growth
8.1. Market Size
8.2. Historic Market Growth, 2016 - 2021, Value ($ Million)
8.2.1. Market Drivers 2016 - 2021
8.2.2. Market Restraints 2016 - 2021
8.3. Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
8.3.1. Market Drivers 2021 - 2026
8.3.2. Market Restraints 2021 - 2026
9. Global Market Segmentation
9.1. Global Healthcare Specialty Enzymes Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
9.2. Global Healthcare Specialty Enzymes Market, Segmentation By Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
9.3. Global Healthcare Specialty Enzymes Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
10. Global Market, Regional And Country Analysis
10.1. Global Healthcare Specialty Enzymes Market, By Region, Historic and Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
10.2. Global Healthcare Specialty Enzymes Market, By Country, Historic and Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11. Asia-Pacific Market
11.1. Summary
11.2. Market Overview
11.2.1. Region Information
11.2.2. Market Information
11.2.3. Background Information
11.2.4. Government Initiatives
11.2.5. Regulations
11.2.6. Regulatory Bodies
11.2.7. Major Associations
11.2.8. Taxes Levied
11.2.9. Corporate Tax Structure
11.2.10. Investments
11.2.11. Major Companies
11.3. Asia-Pacific Healthcare Specialty Enzymes Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
11.4. Asia-Pacific Healthcare Specialty Enzymes Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.5. Asia-Pacific Healthcare Specialty Enzymes Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.6. Asia-Pacific Healthcare Specialty Enzymes Market, Segmentation By Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.7. Asia-Pacific Healthcare Specialty Enzymes Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.8. Asia Pacific Healthcare Specialty Enzymes Market: Country Analysis
11.9. China Market
11.10. Summary
11.11. Market Overview
11.11.1. Country Information
11.11.2. Market Information
11.11.3. Background Information
11.11.4. Government Initiatives
11.11.5. Regulations
11.11.6. Regulatory Bodies
11.11.7. Major Associations
11.11.8. Taxes Levied
11.11.9. Corporate Tax Structure
11.11.10. Investments
11.11.11. Major Companies
11.12. China Healthcare Specialty Enzymes Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
11.13. China Healthcare Specialty Enzymes Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.14. China Healthcare Specialty Enzymes Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.15. China Healthcare Specialty Enzymes Market, Segmentation By Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.16. India Market
11.17. India Healthcare Specialty Enzymes Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
11.18. India Healthcare Specialty Enzymes Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.19. India Healthcare Specialty Enzymes Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.20. India Healthcare Specialty Enzymes Market, Segmentation By Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.21. Japan Market
11.22. Japan Healthcare Specialty Enzymes Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
11.23. Japan Healthcare Specialty Enzymes Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.24. Japan Healthcare Specialty Enzymes Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.25. Japan Healthcare Specialty Enzymes Market, Segmentation By Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.26. Australia Market
11.27. Australia Healthcare Specialty Enzymes Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
11.28. Australia Healthcare Specialty Enzymes Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.29. Australia Healthcare Specialty Enzymes Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.30. Australia Healthcare Specialty Enzymes Market, Segmentation By Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.31. Indonesia Market
11.32. Indonesia Healthcare Specialty Enzymes Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
11.33. Indonesia Healthcare Specialty Enzymes Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.34. Indonesia Healthcare Specialty Enzymes Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.35. Indonesia Healthcare Specialty Enzymes Market, Segmentation By Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.36. South Korea Market
11.37. South Korea Healthcare Specialty Enzymes Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
11.38. South Korea Healthcare Specialty Enzymes Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.39. South Korea Healthcare Specialty Enzymes Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.40. South Korea Healthcare Specialty Enzymes Market, Segmentation By Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12. Western Europe Market
12.1. Summary
12.2. Market Overview
12.2.1. Region Information
12.2.2. Market Information
12.2.3. Background Information
12.2.4. Government Initiatives
12.2.5. Regulations
12.2.6. Regulatory bodies
12.2.7. Major Associations
12.2.8. Taxes Levied
12.2.9. Corporate Tax Structure
12.2.10. Investments
12.2.11. Major Companies
12.3. Western Europe Healthcare Specialty Enzymes Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
12.4. Western Europe Healthcare Specialty Enzymes Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
12.5. Western Europe Healthcare Specialty Enzymes Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.6. Western Europe Healthcare Specialty Enzymes Market, Segmentation By Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.7. Western Europe Healthcare Specialty Enzymes Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.8. Western Europe Healthcare Specialty Enzymes Market: Country Analysis
12.9. UK Market
12.10. UK Healthcare Specialty Enzymes Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
12.11. UK Healthcare Specialty Enzymes Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
12.12. UK Healthcare Specialty Enzymes Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.13. UK Healthcare Specialty Enzymes Market, Segmentation By Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.14. Germany Market
12.15. Germany Healthcare Specialty Enzymes Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
12.16. Germany Healthcare Specialty Enzymes Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
12.17. Germany Healthcare Specialty Enzymes Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.18. Germany Healthcare Specialty Enzymes Market, Segmentation By Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.19. France Market
12.20. France Healthcare Specialty Enzymes Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
12.21. France Healthcare Specialty Enzymes Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
12.22. France Healthcare Specialty Enzymes Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.23. France Healthcare Specialty Enzymes Market, Segmentation By Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13. Eastern Europe Market
13.1. Summary
13.2. Market Overview
13.2.1. Region Information
13.2.2. Market Information
13.2.3. Background Information
13.2.4. Government Initiatives
13.2.5. Regulations
13.2.6. Regulatory Bodies
13.2.7. Major Associations
13.2.8. Taxes Levied
13.2.9. Corporate Tax Structure
13.2.10. Investments
13.2.11. Major Companies
13.3. Eastern Europe Healthcare Specialty Enzymes Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
13.4. Eastern Europe Healthcare Specialty Enzymes Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
13.5. Eastern Europe Healthcare Specialty Enzymes Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.6. Eastern Europe Healthcare Specialty Enzymes Market, Segmentation By Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.7. Eastern Europe Healthcare Specialty Enzymes Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.8. Eastern Europe Healthcare Specialty Enzymes Market: Country Analysis
13.9. Russia Market
13.10. Russia Healthcare Specialty Enzymes Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
13.11. Russia Healthcare Specialty Enzymes Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
13.12. Russia Healthcare Specialty Enzymes Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.13. Russia Healthcare Specialty Enzymes Market, Segmentation By Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14. North America Market
14.1. Summary
14.2. Market Overview
14.2.1. Region Information
14.2.2. Market Information
14.2.3. Background Information
14.2.4. Government Initiatives
14.2.5. Regulations
14.2.6. Regulatory Bodies
14.2.7. Major Associations
14.2.8. Taxes levied
14.2.9. Investments
14.2.10. Major Companies
14.3. North America Healthcare Specialty Enzymes Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
14.4. North America Healthcare Specialty Enzymes Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
14.5. North America Healthcare Specialty Enzymes Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14.6. North America Healthcare Specialty Enzymes Market, Segmentation By Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14.7. North America Healthcare Specialty Enzymes Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14.8. North America Healthcare Specialty Enzymes Market: Country Analysis
14.9. USA Market
14.10. Summary
14.11. Market Overview
14.11.1. Country Information
14.11.2. Market Information
14.11.3. Background Information
14.11.4. Government Initiatives
14.11.5. Regulations
14.11.6. Regulatory bodies
14.11.7. Major Associations
14.11.8. Taxes levied
14.11.9. Corporate tax structure
14.11.10. Investments
14.11.11. Major Companies
14.12. USA Healthcare Specialty Enzymes Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
14.13. USA Healthcare Specialty Enzymes Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
14.14. USA Healthcare Specialty Enzymes Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14.15. USA Healthcare Specialty Enzymes Market, Segmentation By Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15. South America Market
15.1. Summary
15.2. Market Overview
15.2.1. Region Information
15.2.2. Market Information
15.2.3. Background Information
15.2.4. Government Initiatives
15.2.5. Regulations
15.2.6. Regulatory Bodies
15.2.7. Major Associations
15.2.8. Taxes Levied
15.2.9. Corporate Tax Structure
15.2.10. Investments
15.2.11. Major Companies
15.3. South America Healthcare Specialty Enzymes Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
15.4. South America Healthcare Specialty Enzymes Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
15.5. South America Healthcare Specialty Enzymes Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.6. South America Healthcare Specialty Enzymes Market, Segmentation By Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.7. South America Healthcare Specialty Enzymes Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.8. South America Healthcare Specialty Enzymes Market: Country Analysis
15.9. Brazil Market
15.10. Brazil Healthcare Specialty Enzymes Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
15.11. Brazil Healthcare Specialty Enzymes Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
15.12. Brazil Healthcare Specialty Enzymes Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.13. Brazil Healthcare Specialty Enzymes Market, Segmentation By Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
16. Middle East Market
16.1. Summary
16.2. Market Overview
16.2.1. Region Information
16.2.2. Market Information
16.2.3. Background Information
16.2.4. Government Initiatives
16.2.5. Regulations
16.2.6. Regulatory Bodies
16.2.7. Major Associations
16.2.8. Taxes Levied
16.2.9. Corporate Tax Structure
16.2.10. Investments
16.2.11. Major Companies
16.3. Middle East Healthcare Specialty Enzymes Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
16.4. Middle East Healthcare Specialty Enzymes Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
16.5. Middle East Healthcare Specialty Enzymes Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
16.6. Middle East Healthcare Specialty Enzymes Market, Segmentation By Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
16.7. Middle East Healthcare Specialty Enzymes Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
17. Africa Market
17.1. Summary
17.2. Market Overview
17.2.1. Region Information
17.2.2. Market Information
17.2.3. Background Information
17.2.4. Government Initiatives
17.2.5. Regulations
17.2.6. Regulatory Bodies
17.2.7. Major Associations
17.2.8. Taxes Levied
17.2.9. Corporate Tax Structure
17.2.10. Investments
17.2.11. Major Companies
17.3. Africa Healthcare Specialty Enzymes Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
17.4. Africa Healthcare Specialty Enzymes Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
17.5. Africa Healthcare Specialty Enzymes Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
17.6. Africa Healthcare Specialty Enzymes Market, Segmentation By Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
17.7. Africa Healthcare Specialty Enzymes Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
18. Competitive Landscape And Company Profiles
18.1. Company Profiles
18.2. F. Hoffmann-La Roche AG
18.2.1. Company Overview
18.2.2. Products And Services
18.2.3. Business Strategy
18.2.4. Financial Overview
18.3. Merck Millipore
18.3.1. Company Overview
18.3.2. Products And Services
18.3.3. Business Strategy
18.3.4. Financial Overview
18.4. Thermo Fisher Scientific, Inc (Affymetrix, Inc.)
18.4.1. Company Overview
18.4.2. Products And Services.
18.4.3. Business Strategy
18.4.4. Financial Overview
18.5. Codexis Inc.
18.5.1. Company Overview
18.5.2. Products And Services
18.5.3. Business Strategy
18.5.4. Financial Overview
18.6. Sekisui Diagnostics
18.6.1. Company Overview
18.6.2. Products and Services
18.6.3. Business Strategy
18.6.4. Financial Overview
18.7. Advanced Enzymes
18.7.1. Company Overview
18.7.2. Products and Services
18.7.3. Business Strategy
18.7.4. Financial Overview
18.8. New England Biolabs
18.8.1. Company Overview
18.8.2. Products and Services
18.8.3. Business Strategy
18.8.4. Financial Overview
18.9. Promega Corporation
18.9.1. Company Overview
18.9.2. Products and Services
18.9.3. Business Strategy
18.9.4. Financial Overview
19. Key Mergers and Acquisitions
19.1. Kerry Acquired C-LEcta and Enmex
19.2. Roche Acquired TIB Molbiol
19.3. ADM Acquired Deerland Probiotics And Enzymes
19.4. Novozymes Acquired The Data Science Platform Of Biota
19.5. BRAIN Biotech AG Acquired Biocatalysts Ltd.
19.6. Advanced Enzyme Technologies Acquired SciTech Specialties
19.7. Advanced Enzyme Acquired Majority Stake In Scitech Specialties
19.8. Deerland Probiotics & Enzymes Acquired Bifodan A/S
20. Global Healthcare Specialty Enzymes Market Opportunities And Strategies
20.1. Global Healthcare Specialty Enzymes Market In 2026 - Countries Offering Most New Opportunities
20.2. Global Healthcare Specialty Enzymes Market In 2026 - Segments Offering Most New Opportunities
20.3. Global Healthcare Specialty Enzymes Market In 2026 - Growth Strategies
20.3.1. Market Trend Based Strategies
20.3.2. Competitor Strategies
21. Healthcare Specialty Enzymes Market, Conclusions And Recommendations
21.1. Conclusions
21.2. Recommendations
21.2.1. Product
21.2.2. Place
21.2.3. Price
21.2.4. Promotion
21.2.5. People
22. Appendix
22.1. Market Data Sources
22.2. Research Methodology
22.3. Currencies
22.4. About the Publisher
22.5. Copyright and Disclaimer

Executive Summary

Healthcare Specialty Enzymes Global Market Opportunities And Strategies To 2031 from the publisher provides the strategists; marketers and senior management with the critical information they need to assess the global healthcare specialty enzymes market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates
  • Create regional and country strategies on the basis of local data and analysis
  • Identify growth segments for investment
  • Outperform competitors using forecast data and the drivers and trends shaping the market
  • Understand customers based on the latest market research findings
  • Benchmark performance against key competitors
  • Utilize the relationships between key data sets for superior strategizing
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis

Description:

Where is the largest and fastest growing market for healthcare specialty enzymes? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The healthcare specialty enzymes market global report from the publisher answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider healthcare specialty enzymes market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about the healthcare specialty enzymes market
  • Key Trends - Highlights the major trends shaping the global healthcare specialty enzymes market. This section also highlights likely future developments in the market
  • Global Market Size and Growth - Global historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods
  • Regional And Country Analysis - Historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values and growth and market share comparison by region and country
  • Market Segmentation - Contains the market values (2016-2031) and analysis for for segment by type, by source, and by application in the market
  • Regional Market Size and Growth - Regional market size (2021), historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region
  • Competitive Landscape - Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players
  • Key Mergers and Acquisitions - Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years
  • Market Opportunities And Strategies - Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets
  • Conclusions And Recommendations - Includes recommendations for healthcare specialty enzymes providers in terms of product/service offerings, geographic expansion, marketing strategies and target groups
  • Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report

Scope

Markets Covered:

  • 1) By Type: Carbohydrases; Proteases; Lipases; Polymerases And Nucleases; Oxidase And Hydratases; Other Types
  • 2) By Source: Microorganisms; Animals; Plants
  • 3) By Application: Pharmaceuticals; Research And Biotechnology; Diagnostics; Biocatalysts
Companies Mentioned: F. Hoffmann-La Roche AG; Merck Millipore; Thermo Fisher Scientific Inc. (Affymetrix, Inc.); Codexis, Inc.; Sekisui Diagnostics

Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; healthcare specialty enzymes indicators comparison.

Data segmentations:country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • F. Hoffmann-La Roche AG
  • Merck Millipore
  • Thermo Fisher Scientific Inc. (Affymetrix, Inc.)
  • Codexis, Inc.
  • Sekisui Diagnostics

Methodology

Loading
LOADING...